HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 01-11-2008, 08:36 PM   #1
hutchibk
Senior Member
 
hutchibk's Avatar
 
Join Date: Oct 2005
Posts: 3,519
? for Lani and the group who were at SABCS...

Do any of you remember hearing talks about women who's menstrual cycles have started to return while still on AI's - after a few years of being on them? This is not for me, but for a friend... I seem to remember either seeing a poster or hearing a mention of it, but just can't wrap my mind around what the info was.

Anyone?
__________________
Brenda

NOV 2012 - 9 yr anniversary
JULY 2012 - 7 yr anniversary stage IV (of 50...)

Nov'03~ dX stage 2B
Dec'03~
Rt side mastectomy, Her2+, ER/PR+, 10 nodes out, one node positive
Jan'04~
Taxotere/Adria/Cytoxan x 6, NED, no Rads, Tamox. 1 year, Arimadex 3 mo., NED 14 mo.
Sept'05~
micro mets lungs/chest nodes/underarm node, Switched to Aromasin, T/C/H x 7, NED 6 months - Herceptin only
Aug'06~
micro mets chest nodes, & bone spot @ C3 neck, Added Taxol to Herceptin
Feb'07~ Genetic testing, BRCA 1&2 neg

Apr'07~
MRI - two 9mm brain mets & 5 punctates, new left chest met, & small increase of bone spot C3 neck, Stopped Aromasin
May'07~
Started Tykerb/Xeloda, no WBR for now
June'07~
MRI - stable brain mets, no new mets, 9mm spots less enhanced, CA15.3 down 45.5 to 9.3 in 10 wks, Ty/Xel working magic!
Aug'07~
MRI - brain mets shrunk half, NO NEW BRAIN METS!!, TMs stable @ 9.2
Oct'07~
PET/CT & MRI show NED
Apr'08~
scans still show NED in the head, small bone spot on right iliac crest (rear pelvic bone)
Sept'08~
MRI shows activity in brain mets, completed 5 fractions/5 consecutive days of IMRT to zap the pesky buggers
Oct'08~
dropped Xeloda, switched to tri-weekly Herceptin in combo with Tykerb, extend to tri-monthly Zometa infusion
Dec'08~
Brain MRI- 4 spots reduced to punctate size, large spot shrunk by 3mm, CT of torso clear/pelvis spot stable
June'09~
new 3-4mm left cerrebellar spot zapped with IMRT targeted rads
Sept'09~
new 6mm & 1 cm spots in pituitary/optic chiasm area. Rx= 25 days of 3D conformal fractionated targeted IMRT to the tumors.
Oct'09~
25 days of low dose 3D conformal fractionated targeted IMRT to the bone mets spot on rt. iliac crest that have been watching for 2 years. Added daily Aromasin back into treatment regimen.
Apr'10~ Brain MRI clear! But, see new small spot on adrenal gland. Change from Aromasin back to Tamoxifen.
June'10~ Tumor markers (CA15.3) dropped from 37 to 23 after one month on Tamoxifen. Continue to monitor adrenal gland spot. Remain on Tykerb/Herceptin/Tamoxifen.
Nov'10~ Radiate positive mediastinal node that was pressing on recurrent laryngeal nerve, causing paralyzed larynx and a funny voice.
Jan'11~ MRI shows possible activity or perhaps just scar tissue/necrotic increase on 3 previously treated brain spots and a pituitary spot. 5 days of IMRT on 4 spots.
Feb'11~ Enrolled in T-DM1 EAP in Denver, first treatment March 25, 2011.
Mar'11~ Finally started T-DM1 EAP in Denver at Rocky Mountain Cancer Center/Rose on Mar. 25... hallelujah.

"I would rather be anecdotally alive than statistically dead."
hutchibk is offline   Reply With Quote
Old 01-11-2008, 08:45 PM   #2
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
I think it was a poster...if you go to the SABCS website

and browse through the posters you may find it--I don't think they are indexed in any way, but perhaps there is a search

I didn't spend time looking at it, so unfortunately I cannot offer any more info

Sorry!
Lani is offline   Reply With Quote
Old 01-11-2008, 08:59 PM   #3
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
it seems the hack-attack erased my posts on that technology so here is some more

besides nanospheres(nanoshells) there are also gold nanotubes, nanorods and nanocages--

Here is just a bit of info:

Immunonanoshells for Selective Photothermal Therapy (Abstract 3198) and Nanoshells for Combined Cancer Therapy and Imaging in vivo (Abstract 2711)

Researchers at Rice University are working on a novel and systematic approach to cancer treatment that involves the use of advanced technologies that are by themselves harmless − but appear to offer potent cancer-killing properties when used together.

This tactic focuses on two main ingredients: structures called "nanoshells," which are microscopic balls consisting of a silica core coated with a thin layer of gold and, secondly, near infrared light (NIR). Used alone, nanoshells are non-toxic and can be excreted with no ill effect because gold is biologically compatible. Near-infrared light delivered by a laser has minimal interaction with components found in tissue, and so also does not harm the body.

But when nanoshells are injected into an experimental animal with cancer, they accumulate in the tumor; the addition of NIR laser light heats up their gold shell, causing the particles to destroy tumor cells. Furthermore, because of their size − a few nanometers, or billionths of a meter, in diameter − these nanoshells interact with light in specific ways, and can be "tuned" to discrete destructive wavelengths by varying the size of the core and the shell.

Two new studies advance the use of this technology. One, reported by bioengineering graduate student Andre Gobin, is the first to demonstrate how nanoshells and imaging can be used together to treat tumors in animal models. Gobin and a team of Rice researchers injected nanoshells into the blood stream of mice implanted with colon cancer knowing, based on previous experiments, that the nanoshells would preferentially accumulate in the tumors. This occurs because blood vessels that develop in fast-growing solid tumors are ill-formed and permeable, and nanoshells traveling through blood end up spilling out of these leaky vessels into tumor tissue. Once there, the tumor only slowly excretes them as waste. The nanoshells are also hidden from the immune system because they are "shielded" by a protective polymer coating, poly-(ethylene glycol) or PEG. This does not change the properties of the nanoshells but renders them "invisible" to the body’s natural defense mechanism.

Twenty hours after the nanoshells were injected, the researchers imaged their presence in the tumor by using a small hand-held optical coherence tomography (OCT) probe similar to that which dermatologists can use to find skin cancers. According to Gobin, the researchers hope that these probes, already commercially available, can be adapted to both image nanoshells in tumors with higher resolution, and then therapeutically heat them up with a secondary laser coupled to the probe, making nanoshell-assisted therapy user friendly.

In this study, however, a different laser source was used to irradiate the tumors in the experimental group of mice. At the end of the study, 82 percent of the mice survived in the experimental group, but all mice in the control group that did not receive nanoshells and laser therapy had to be sacrificed because of their large tumors.

The second Rice University study aims to improve the method of delivery of nanoshells to a tumor. Although the leaky blood vessel strategy can passively dump nanoshells into tumors, it cannot "find" tiny cancers that have metastasized and have not yet "recruited" a substantial system of blood vessels to feed them. To counteract that, researchers have fused a nanoshell to an antibody; the idea behind such "immunonanoshells" is to have a targeted nanoshell that can find a specific type of cancer wherever it may hide, says study author, bioengineering graduate student Amanda Lowery

In the study that Lowery reports, the researchers hooked "Y"-shaped anti-HER2 antibodies to nanoshells, and the antibody bound to HER2 over-expressing breast cancers. They then applied these immunonanoshells to the top of laboratory breast cancer cells, and used laser light to heat the agent. Researchers then stained the cells to see which lived and found that only HER2-expressing cells which had bound nanoshells and were exposed to the near infrared laser, died. Cells that were not exposed to laser light also survived, suggesting that the antibody-nanoshell treatment effectively destroyed HER2 over-expressing cancer cells. The research team is now planning to test this strategy in animal models.

According to Gobin, Lowery, and the Rice University faculty they work with, nanotechnology to treat cancer takes advantage of much of the biology already known about the disease, and marries it to a suite of techniques based on next era technology.
Lani is offline   Reply With Quote
Old 01-12-2008, 07:09 AM   #4
Becky
Senior Member
 
Becky's Avatar
 
Join Date: Sep 2005
Location: Stockton, NJ
Posts: 4,179
Femara is used off label to assist in helping women going under invitro to produce more eggs for harvest.

If you search back to the summer of 2005, you will see my panicked posts about getting my period back while on Arimidex. I had been on Tamoxifen about 2 months but wanted to be on an AI due to being Her2 and having no progesterone receptor and only a moderate estrogen receptor. That said, I felt I was a great candidate for Tamoxifen resistance. Since my period hadn't returned and I was 46, I had my onc run my hormones (FSH, LH and estradiol) and it showed I was postmenopausal so I switched to Arimidex just prior to starting Herceptin (4 months after my last Taxol). This was mid June. In the beginning of August my period returned. I stopped Arimidex (as it is useless in this situation) and called my gyne. Three weeks later I had an ooph and a couple of weeks after that I restarted the Arimidex.

When I went to the gyne for a presurgical ultrasound, it was clear I was up and running with a double ovulation on my left ovary and the ovaries were clearly functioning. (Thankfully my husband had a vasectomy many years prior or I could have gotten nabbed with twins only a few months out from treatment and wouldn't have be able to be on an antihormonal or Herceptin). Just call me mama!
__________________
Kind regards

Becky

Found lump via BSE
Diagnosed 8/04 at age 45
1.9cm tumor, ER+PR-, Her2 3+(rt side)
2 micromets to sentinel node
Stage 2A
left 3mm DCIS - low grade ER+PR+Her2 neg
lumpectomies 9/7/04
4DD AC followed by 4 DD taxol
Used Leukine instead of Neulasta
35 rads on right side only
4/05 started Tamoxifen
Started Herceptin 4 months after last Taxol due to
trial results and 2005 ASCO meeting & recommendations
Oophorectomy 8/05
Started Arimidex 9/05
Finished Herceptin (16 months) 9/06
Arimidex Only
Prolia every 6 months for osteopenia

NED 18 years!

Said Christopher Robin to Pooh: "You must remember this: You're braver than you believe and stronger than you seem and smarter than you think"
Becky is offline   Reply With Quote
Old 01-12-2008, 07:15 AM   #5
Becky
Senior Member
 
Becky's Avatar
 
Join Date: Sep 2005
Location: Stockton, NJ
Posts: 4,179
http://www.medpagetoday.com/OBGYN/Infertility/tb/3144
Here is one article on using Femara for infertility. I know I read a better one than this.Anyway - I don't remember seeing anything in San Antonio on this but it is true that AIs can make your period return if you weren't a bonefide postmenopausal woman (take it from me). And they are used to help induce ovulation in premenopausal women (twins!!!!ugh)
__________________
Kind regards

Becky

Found lump via BSE
Diagnosed 8/04 at age 45
1.9cm tumor, ER+PR-, Her2 3+(rt side)
2 micromets to sentinel node
Stage 2A
left 3mm DCIS - low grade ER+PR+Her2 neg
lumpectomies 9/7/04
4DD AC followed by 4 DD taxol
Used Leukine instead of Neulasta
35 rads on right side only
4/05 started Tamoxifen
Started Herceptin 4 months after last Taxol due to
trial results and 2005 ASCO meeting & recommendations
Oophorectomy 8/05
Started Arimidex 9/05
Finished Herceptin (16 months) 9/06
Arimidex Only
Prolia every 6 months for osteopenia

NED 18 years!

Said Christopher Robin to Pooh: "You must remember this: You're braver than you believe and stronger than you seem and smarter than you think"

Last edited by Becky; 01-14-2008 at 06:41 AM..
Becky is offline   Reply With Quote
Old 01-12-2008, 07:58 PM   #6
dlaxague
Senior Member
 
Join Date: May 2006
Posts: 221
'don't remember either, but...

.... bottom line as I understand it is that if menstrual cycles occur while on an AI, it means a change is needed asap - either to Tamoxifen or to ovarian suppression with drugs or surgery. Right? I did try to search the SABCS website/posters/abstracts but couldn't find it.

Debbie Laxague
__________________
3/01 ~ Age 49, occult primary announced by large axillary node found by my husband. Multiple CBE's, mammogram, U/S could not find anything in the breast. Axillary node biopsy - pathology said + for "mets above diaphragm, probably breast".
4/01 ~ Bilateral mastectomies (LMRM, R simple) - 1.2cm IDC was found at pathology.
5 of 11 axillary nodes positive, largest = 6cm. Stage IIIA
ERPR 5%/1% (re-done later at Baylor, both negative at zero).
HER2neu positive by IHC and FISH (8.89).
Lymphovascular invasion, grade 3, 8/9 modified SBR.
TX: Control of arm of NSABP B-31's adjuvant Herceptin trial (no Herceptin): A/C x 4 and Taxol x 4 q3weeks, then rads. Arimidex for two years, stopped after second patholgy opinion.
dlaxague is offline   Reply With Quote
Old 01-13-2008, 01:18 AM   #7
hutchibk
Senior Member
 
hutchibk's Avatar
 
Join Date: Oct 2005
Posts: 3,519
Thanks Becky and DL... there was so much info, that I have vague recollections, but specifics are hard to conjure up.
__________________
Brenda

NOV 2012 - 9 yr anniversary
JULY 2012 - 7 yr anniversary stage IV (of 50...)

Nov'03~ dX stage 2B
Dec'03~
Rt side mastectomy, Her2+, ER/PR+, 10 nodes out, one node positive
Jan'04~
Taxotere/Adria/Cytoxan x 6, NED, no Rads, Tamox. 1 year, Arimadex 3 mo., NED 14 mo.
Sept'05~
micro mets lungs/chest nodes/underarm node, Switched to Aromasin, T/C/H x 7, NED 6 months - Herceptin only
Aug'06~
micro mets chest nodes, & bone spot @ C3 neck, Added Taxol to Herceptin
Feb'07~ Genetic testing, BRCA 1&2 neg

Apr'07~
MRI - two 9mm brain mets & 5 punctates, new left chest met, & small increase of bone spot C3 neck, Stopped Aromasin
May'07~
Started Tykerb/Xeloda, no WBR for now
June'07~
MRI - stable brain mets, no new mets, 9mm spots less enhanced, CA15.3 down 45.5 to 9.3 in 10 wks, Ty/Xel working magic!
Aug'07~
MRI - brain mets shrunk half, NO NEW BRAIN METS!!, TMs stable @ 9.2
Oct'07~
PET/CT & MRI show NED
Apr'08~
scans still show NED in the head, small bone spot on right iliac crest (rear pelvic bone)
Sept'08~
MRI shows activity in brain mets, completed 5 fractions/5 consecutive days of IMRT to zap the pesky buggers
Oct'08~
dropped Xeloda, switched to tri-weekly Herceptin in combo with Tykerb, extend to tri-monthly Zometa infusion
Dec'08~
Brain MRI- 4 spots reduced to punctate size, large spot shrunk by 3mm, CT of torso clear/pelvis spot stable
June'09~
new 3-4mm left cerrebellar spot zapped with IMRT targeted rads
Sept'09~
new 6mm & 1 cm spots in pituitary/optic chiasm area. Rx= 25 days of 3D conformal fractionated targeted IMRT to the tumors.
Oct'09~
25 days of low dose 3D conformal fractionated targeted IMRT to the bone mets spot on rt. iliac crest that have been watching for 2 years. Added daily Aromasin back into treatment regimen.
Apr'10~ Brain MRI clear! But, see new small spot on adrenal gland. Change from Aromasin back to Tamoxifen.
June'10~ Tumor markers (CA15.3) dropped from 37 to 23 after one month on Tamoxifen. Continue to monitor adrenal gland spot. Remain on Tykerb/Herceptin/Tamoxifen.
Nov'10~ Radiate positive mediastinal node that was pressing on recurrent laryngeal nerve, causing paralyzed larynx and a funny voice.
Jan'11~ MRI shows possible activity or perhaps just scar tissue/necrotic increase on 3 previously treated brain spots and a pituitary spot. 5 days of IMRT on 4 spots.
Feb'11~ Enrolled in T-DM1 EAP in Denver, first treatment March 25, 2011.
Mar'11~ Finally started T-DM1 EAP in Denver at Rocky Mountain Cancer Center/Rose on Mar. 25... hallelujah.

"I would rather be anecdotally alive than statistically dead."
hutchibk is offline   Reply With Quote
Old 01-13-2008, 03:20 PM   #8
Chelee
Senior Member
 
Chelee's Avatar
 
Join Date: Feb 2006
Location: Southern, CA
Posts: 2,511
I know of a few women that are on another board that had this problem. I don't think it was years after words though? I know I was in chemo-pause and it was months later that I signs of my period starting and we checked my estradiol and FSH and I was back to being very peri-meno. So I do know it happens.

Becky...that link you have in your post doesn't work for me? Not sure if its just a problem on my end?

Take care MAMA! lol

Chelee
__________________
DX: 12-20-05 - Stage IIIA, Her2/Neu, 3+++,Er & Pr weakly positive, 5 of 16 pos nodes.
Rt. MRM on 1-3-06 -- No Rads due to compromised lungs.
Chemo started 2-7-06 -- TCH - - Finished 6-12-06
Finished yr of wkly herceptin 3-19-07
3-15-07 Lt side prophylactic simple mastectomy. -- Ooph 4-05-07
9-21-09 PET/CT "Recurrence" to Rt. axllia, Rt. femur, ilium. Possible Sacrum & liver? Now stage IV.
9-28-09 Loading dose of Herceptin & started Zometa
9-29-09 Power Port Placement
10-24-09 Mass 6.4 x 4.7 cm on Rt. femur head.
11-19-09 RT. Femur surgery - Rod placed
12-7-09 Navelbine added to Herceptin/Zometa.
3-23-10 Ten days of rads to RT femur. Completed.
4-05-10 Quit Navelbine--Herceptin/Zometa alone.
5-4-10 Appt. with Dr. Slamon to see what is next? Waiting on FISH results from femur biopsy.
Results to FISH was unsuccessful--this happens less then 2% of the time.
7-7-10 Recurrence to RT axilla again. Back to UCLA for options.
Chelee is offline   Reply With Quote
Old 01-14-2008, 08:55 AM   #9
hutchibk
Senior Member
 
hutchibk's Avatar
 
Join Date: Oct 2005
Posts: 3,519
It seems to be a fairly overlooked area of research - even according to my onc... very little info about it and what to do about it. Hmmmm. Time for the advocates to get a little noisy, perhaps?
__________________
Brenda

NOV 2012 - 9 yr anniversary
JULY 2012 - 7 yr anniversary stage IV (of 50...)

Nov'03~ dX stage 2B
Dec'03~
Rt side mastectomy, Her2+, ER/PR+, 10 nodes out, one node positive
Jan'04~
Taxotere/Adria/Cytoxan x 6, NED, no Rads, Tamox. 1 year, Arimadex 3 mo., NED 14 mo.
Sept'05~
micro mets lungs/chest nodes/underarm node, Switched to Aromasin, T/C/H x 7, NED 6 months - Herceptin only
Aug'06~
micro mets chest nodes, & bone spot @ C3 neck, Added Taxol to Herceptin
Feb'07~ Genetic testing, BRCA 1&2 neg

Apr'07~
MRI - two 9mm brain mets & 5 punctates, new left chest met, & small increase of bone spot C3 neck, Stopped Aromasin
May'07~
Started Tykerb/Xeloda, no WBR for now
June'07~
MRI - stable brain mets, no new mets, 9mm spots less enhanced, CA15.3 down 45.5 to 9.3 in 10 wks, Ty/Xel working magic!
Aug'07~
MRI - brain mets shrunk half, NO NEW BRAIN METS!!, TMs stable @ 9.2
Oct'07~
PET/CT & MRI show NED
Apr'08~
scans still show NED in the head, small bone spot on right iliac crest (rear pelvic bone)
Sept'08~
MRI shows activity in brain mets, completed 5 fractions/5 consecutive days of IMRT to zap the pesky buggers
Oct'08~
dropped Xeloda, switched to tri-weekly Herceptin in combo with Tykerb, extend to tri-monthly Zometa infusion
Dec'08~
Brain MRI- 4 spots reduced to punctate size, large spot shrunk by 3mm, CT of torso clear/pelvis spot stable
June'09~
new 3-4mm left cerrebellar spot zapped with IMRT targeted rads
Sept'09~
new 6mm & 1 cm spots in pituitary/optic chiasm area. Rx= 25 days of 3D conformal fractionated targeted IMRT to the tumors.
Oct'09~
25 days of low dose 3D conformal fractionated targeted IMRT to the bone mets spot on rt. iliac crest that have been watching for 2 years. Added daily Aromasin back into treatment regimen.
Apr'10~ Brain MRI clear! But, see new small spot on adrenal gland. Change from Aromasin back to Tamoxifen.
June'10~ Tumor markers (CA15.3) dropped from 37 to 23 after one month on Tamoxifen. Continue to monitor adrenal gland spot. Remain on Tykerb/Herceptin/Tamoxifen.
Nov'10~ Radiate positive mediastinal node that was pressing on recurrent laryngeal nerve, causing paralyzed larynx and a funny voice.
Jan'11~ MRI shows possible activity or perhaps just scar tissue/necrotic increase on 3 previously treated brain spots and a pituitary spot. 5 days of IMRT on 4 spots.
Feb'11~ Enrolled in T-DM1 EAP in Denver, first treatment March 25, 2011.
Mar'11~ Finally started T-DM1 EAP in Denver at Rocky Mountain Cancer Center/Rose on Mar. 25... hallelujah.

"I would rather be anecdotally alive than statistically dead."
hutchibk is offline   Reply With Quote
Old 01-15-2008, 12:10 AM   #10
TSund
Senior Member
 
TSund's Avatar
 
Join Date: May 2007
Location: DFW area (TX)
Posts: 431
A young bs survivor we met at the hospital who is now a stage IV patient was mistakenly given treatment with an AI pre-menopause by her oncologist at original diagnosis. This was when her cancer raged out of control; it was like adding fuel to the fire. From what I understand, functioning ovaries can be told to go into OVERDRIVE by the AI drugs ending up with more estrogen in the body, not less. Becky, you handled things smartly.
__________________
Terri, spouse of Ruth, Dallas/Ft. Worth area
Ruth dx 05/01/07 (age 50) Filipino
multifocal, several tumors .5 -2.5 cm, large area
Breast MRI showed 2 enlarged nodes, not palpable
100%ER+, 95%PR+, HER2+++
6x pre-surgery TCH chemo finished 9/15/7 Dramatic tumor shrinkage
1 year Herceptin till 6/08
MRM 10/11/07, SNB: 0/4 nodes + Path: tumors reduced to only a few "scattered cells"
now 50% ER+, PR- ???
Rads finished 1/16/08
Added Tamoxifen,
Finished Herceptin 05/08
NOW is the time to appreciate life to the fullest.
TSund is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 02:15 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter